Suppr超能文献

基于结果优化和成本效益的口腔矫治器和/或仰卧位避免疗法选择标准。

Criteria for oral appliance and/or supine avoidance therapy selection based on outcome optimization and cost-effectiveness.

机构信息

Sleep and Respiratory, Advanced Brain Monitoring, Inc, Carlsbad, CA, USA.

Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

出版信息

J Med Econ. 2021 Jan-Dec;24(1):757-763. doi: 10.1080/13696998.2021.1930549.

Abstract

AIM

Produce empirical support for further enhancements to a therapy selection protocol for obstructive sleep apnea (OSA) patients intolerant of positive airway pressure.

METHODS

A retrospective analysis was conducted in 101 men and 69 women patients. Two-night home sleep apnea studies were conducted at baseline and with a trial oral appliance. Twenty-minutes in-position sleep was required to compute supine and non-supine apnea-hypopnea indexes (AHI). Data analyses were applied after stratification by sex and response to oral appliance therapy (OAT), and the results used for to calculate incremental cost-effectiveness ratios (ICER).

RESULTS

Compared with men, women had significantly lower pre-treatment supine and non-supine AHI values ( < .05). OAT non-responders had higher non-supine AHIs, resulting in less positional-OSA and more cases with severe OSA ( < .05). Across the cohort, 21% had positional-OSA with a pre-treatment non-supine AHI < 5 events/h. In those who met this criterion, supine avoidance therapy (SAT) could have reduced the AHI values more than OAT by an average of 33% ( < .0001). The ICER for SAT instead of OAT in this group was negative, a condition that only occurs when one therapy is both less expensive and more effective than the other. A greater proportion of non-responders had post-OAT overall AHI ≥ 10 events/h with residual positional-OSA compared with responders ( < .0001). Combination therapy could reduce the AHI values by an average of 68%, resulting in ICER estimates five-times less than the reimbursement decision-making threshold.

CONCLUSIONS AND LIMITATIONS

Based on pre-treatment non-supine AHI values, SAT would provide a superior first-line treatment outcome as compared to OAT in 21% of patients diagnosed with OSA. SAT would also provide a cost-effective adjuvant to OAT in an additional 15% of cases. The benefit of SAT could not be determined in one-fifth of the cohort who slept exclusively supine.

摘要

目的

为不耐受正压通气治疗的阻塞性睡眠呼吸暂停(OSA)患者的治疗选择方案提供进一步改进的实证支持。

方法

对 101 名男性和 69 名女性患者进行回顾性分析。在基线和试用口腔矫治器时进行了两晚的家庭睡眠呼吸暂停研究。需要 20 分钟的在位睡眠来计算仰卧位和非仰卧位呼吸暂停低通气指数(AHI)。根据性别和口腔矫治器治疗(OAT)反应进行分层后进行数据分析,并使用计算增量成本效益比(ICER)。

结果

与男性相比,女性的治疗前仰卧位和非仰卧位 AHI 值显著较低(<0.05)。OAT 无反应者的非仰卧位 AHI 较高,导致体位性 OSA 较少,严重 OSA 较多(<0.05)。在整个队列中,21%的患者有体位性 OSA,治疗前非仰卧位 AHI<5 次/h。在符合这一标准的患者中,仰卧位回避治疗(SAT)可以使 AHI 值降低 33%(<0.0001),平均降低 33%。在这一组中,SAT 而不是 OAT 的 ICER 为负值,这种情况仅在一种治疗既便宜又比另一种更有效时才会发生。与反应者相比,OAT 后无反应者的总体 AHI≥10 次/h 伴残留体位性 OSA 的比例更高(<0.0001)。联合治疗可使 AHI 值平均降低 68%,导致 ICER 估计值比报销决策阈值低五倍。

结论和局限性

根据治疗前非仰卧位 AHI 值,与 OAT 相比,SAT 将为 21%的 OSA 患者提供更好的一线治疗效果。SAT 还将为另外 15%的病例提供具有成本效益的 OAT 辅助治疗。在五分之一的仅仰卧位睡眠的队列中,无法确定 SAT 的益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验